Accretive Wealth Partners’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$291K Buy
13,894
+1,629
+13% +$34.4K 0.08% 144
2025
Q4
$259K Hold
12,265
0.08% 138
2025
Q3
$260K Buy
12,265
+2,632
+27% +$55.4K 0.08% 134
2025
Q2
$203K Buy
+9,633
New +$199K 0.07% 146

Other funds holding IBDW

Accretive Wealth Partners's IBDW Position: Q1 2026 in Review

Accretive Wealth Partners increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 13% in Q1 2026, buying an estimated $34.4K and bringing the position to 13,894 shares worth $291K. The position accounts for 0.08% of the portfolio, ranked #144.

Accretive Wealth Partners first reported a position in IBDW in Q2 2025 and has held it in 4 quarters since. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

  • Accretive Wealth Partners held 13,894 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $291K as of Q1 2026.
  • Accretive Wealth Partners bought 1,629 iShares iBonds Dec 2031 Term Corporate ETF shares in Q1 2026, an estimated $34.4K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.08% of Accretive Wealth Partners's portfolio in Q1 2026, its #144 holding.
  • Accretive Wealth Partners first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q2 2025 and has held it in 4 quarters since.
  • 288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on Accretive Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.